Sort
23,748 grants matching “melanoma”
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI
$452,639Thomas G Graeber · University Of California Los Angeles · P01 · FY2017 · CA
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI
$452,639Thomas G Graeber · University Of California Los Angeles · P01 · FY2016 · CA
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI
$452,639Thomas G Graeber · University Of California Los Angeles · P01 · FY2015 · CA
Targeting Tregs in the solid tumor microenvironment by modulating metabolite signaling
$452,544Sinãad Kinsella · Fred Hutchinson Cancer Center · R21 · FY2024 · CA
VEGFs in tumor lymphatic metastasis
$452,526Harold Fisher Dvorak · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA
CONFORMAL RADIOACTIVE PLAQUES FOR INTRAOCULAR MELANOMA
$452,474Radiomed Corporation · R44 · FY2001 · EY
Palliative Care: Maximizing Patient Preference
$452,406Donald H Taylor · Duke University · R01 · FY2010 · HS
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
$452,287Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$452,151John H Sampson · Duke University · R01 · FY2012 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$452,079Chuan-Yuan Li · Duke University · R01 · FY2019 · CA
Computer aided diagnosis of cancer metastases in the brain
$451,732Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2019 · LM
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$451,542Shivaani Kummar · Oregon Health & Science University · R01 · FY2021 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$451,530Rohan Fernandes · George Washington University · R37 · FY2023 · CA
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
$451,473Carolyn J. Heckman · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · CA
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies
$451,382Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2020 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$451,326Andrea Facciabene · University Of Pennsylvania · R01 · FY2018 · CA
Tumor Cell Dependence on Host Metabolism
$451,234Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA
ATF2 in DNA damage response.
$451,222Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2008 · CA
Role of Tumor in Therapeutic Response and Resistance
$451,222Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2013 · CA
Antigenic Determinants on HLA-B7 and -A2
$451,153Victor H. Engelhard · University Of Virginia · R01 · FY2010 · CA
Epigenetic regulation of exhausted CD8 T cells via the miR-29a-TET2 axis
$451,004Erietta Stelekati · University Of Miami School Of Medicine · R01 · FY2025 · AI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI
$450,906Thomas G Graeber · University Of California Los Angeles · P01 · FY2013 · CA
PATHOGENESIS OF FEVER IN HUMANS
$450,827University Of Colorado Denver · R01 · FY2001 · AI